ClinicalTrials.Veeva

Menu

Non-Inferiority Study to Compare the Effectiveness of the Seldinger Over-the-Wire Technique and the Modified Seldinger Technique

J

Jena University Hospital

Status

Completed

Conditions

Effectiveness and Safety of the Seldinger Wire Technique Using a 145 cm Guidewire With the Modified Seldinger Technique Using a 70 cm Guidewire

Treatments

Device: Angiodynamic Bioflo Picc IR-KIT (145 cm guidewire) or
Device: Angiodynamic Bioflo Picc MST-KIT (70 cm guidewire)

Study type

Interventional

Funder types

Other

Identifiers

NCT04303052
5385-12/17

Details and patient eligibility

About

Peripherally inserted central venous catheter lines (PICC-line) are successfully used since many years in patients who need long-term frequent IV therapy. The PICC placement is performed under fluoroscopy The study objective is to compare the effectiveness and safety of the Seldinger wire technique (over-the-wire) using a 145 cm guidewire with the modified Seldinger technique using a 70 cm guidewire.

Full description

The referral of patients with indication to PICC-line implantation at the institute of diagnostic and interventional radiology occurs through different departments of the University Hospital Jena. The patients are registered for radiological treatment and checked again by a radiologist if a PICC-line implantation is indicated. If this is the case, the radiologist conducts an informed consent discussion with the patient about possible complications and risks during intervention and informs him also about a possible study participation. After signature of the written informed consent, the patient is included. He can, at any time, withdraw his consent. On the intervention day, the patient is randomly assigned to one of the two study arms through envelope (145 cm vs 70 cm). The intervention time is documented. After intervention, the patient is transferred back to the ward or sent home. The examination of the puncture site before discharge is performed by a ward physician or by the family doctor.

Within 2 weeks after PICC-line implantation, the treating physician is contacted and questioned about possible complications (catheter occlusion, haematoma, infection of the puncture site, arm vein thrombosis, pain, etc.), that are then thoroughly documented.

Enrollment

58 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female, male
  • adults ≥ 18 years
  • medical indication for Power-PICC-Line catheter implantation because of chemotherapy or parenertal nutrition
  • in- and outpatients

Exclusion criteria

  • age < 18 years
  • systemic infection
  • local infection of the interventional location
  • known allergy to used material
  • general contraindication of Power-PICC-Line catheter implantation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

58 participants in 2 patient groups

over-the-wire technique with 145 cm guidewire
Active Comparator group
Description:
Catheter tip placement using Seldinger over-the-wire technique with 145 cm guidewire
Treatment:
Device: Angiodynamic Bioflo Picc IR-KIT (145 cm guidewire) or
modified technique with 70 cm guidewire
Active Comparator group
Description:
Catheter tip placement using Seldinger modified technique with 70 cm guidewire
Treatment:
Device: Angiodynamic Bioflo Picc MST-KIT (70 cm guidewire)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems